Clinical Trials Directory

Trials / Completed

CompletedNCT05902819

Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories

An Investigation of the Effect of MMP-9 Inhibition With Minocycline on the Reconsolidation of Intrusive Trauma- or Cocaine-related Memories

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
138 (actual)
Sponsor
Psychiatric University Hospital, Zurich · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

An investigation of the effect of matrix-metalloproteinase-(MMP)-9 inhibition with minocycline on the reconsolidation of trauma- or cocaine-related memories

Detailed description

Intrusive memories are involuntary recollections of past emotional events that can become pathological and persist over time, particularly in post-traumatic stress disorder (PTSD) and cocaine use disorders (CUD). Both PTSD and CUD are characterised by a hypersensitivity and -reactivity to cue-elicited memory reactivation and exhibit common neurological alterations, suggesting shared underlying mechanisms. As intrusive memories significantly contribute to maintaining the cycle of relapse in both disorders, it is important to find a way to attenuate them successfully. Research on memory reconsolidation has led to the development of different (pharmacological) approaches to disrupt the process, which have, however, yielded mixed and unspecific effects so far. The present project aims to investigate the effect of MMP-9 inhibition with minocycline on the reconsolidation of intrusive memories in individuals with CUD or PTSD. Participants will be randomly assigned to a minocycline or placebo group. The study comprises a total of 5 visits during 3 weeks and one follow-up online survey (3 months after the intervention). Participants will receive the study medication before two imagery script-guided memory activation sessions. An ecological momentary assessment (EMA) approach will be employed to track intrusive memories, and glutamate concentration and neural activation will be measured with magnetic resonance spectroscopy (MRS) and functional magnetic resonance (fMRI), respectively, before and after the two imagery sessions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALImageryGuided imagery of personal trauma- or cocaine-related memory approximately 120min after study medication was given.
DRUGMinocyclineSingle dose of minocycline (200mg) at each of two imagery sessions; Minocycline is given orally in form of a capsule.
DRUGPlaceboSingle dose of mannitol (100%) at each of two imagery sessions; Placebo is given orally in form of a capsule.

Timeline

Start date
2023-05-10
Primary completion
2026-03-02
Completion
2026-03-02
First posted
2023-06-15
Last updated
2026-03-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05902819. Inclusion in this directory is not an endorsement.